• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Ronald D. Geraty, MD, CEO, Alere Medical, Inc.

Article

Ronald Geraty, MD, says Alere is now the second-largest health management company in the industry.

Ronald D. Geraty, MD
CEO, Alere
Reno, Nev.

Deviating from the usual DM approach of randomly calling individuals to identify who needs help, enrolling them in a DM program and providing assistance, Alere relies on aggregate data from many sources to find who is at risk. Its programs integrate biometric screenings and monitoring, as exemplified by the Alere Heart Failure Program. The program puts a monitor in a patient's home to track weight and heart failure symptoms and relays actionable and real-time information to physicians. "We use technological solutions to help people better manage their health by communicating with patients several times a day through a variety of touch points," Dr. Geraty says.

Prior to joining Alere, Dr. Geraty served as CEO of American Imaging Management and was a Research Fellow at the Division of Healthcare Policy and Research at Harvard Medical School. He holds a medical degree from Loma Linda University in Loma Linda, Calif.

He was also named a Managed Healthcare Executive Leader in Disease Management in 2004.

Related Content
© 2024 MJH Life Sciences

All rights reserved.